| The outcome of COVID‐19 in patients with hematological malignancy TN Yigenoglu, N Ata, F Altuntas, S Bascı, MS Dal, S Korkmaz, ... Journal of medical virology 93 (2), 1099-1104, 2021 | 136 | 2021 |
| The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive … S Guldiken, M Demir, E Arikan, B Turgut, S Azcan, M Gerenli, A Tugrul Thrombosis research 119 (1), 79-84, 2007 | 118 | 2007 |
| Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study L Kaynar, F Altuntas, I Aydogdu, B Turgut, I Kocyigit, SK Hacıoglu, ... Transfusion and Apheresis Science 38 (2), 109-115, 2008 | 93 | 2008 |
| Increased circulating platelet–neutrophil, platelet–monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study GE Pamuk, Ö Vural, B Turgut, M Demir, H Ümit, A Tezel American journal of hematology 81 (10), 753-759, 2006 | 90 | 2006 |
| Convalescent plasma therapy in patients with COVID-19 F Altuntas, N Ata, TN Yigenoglu, S Bascı, MS Dal, S Korkmaz, ... Transfusion and Apheresis Science 60 (1), 102955, 2021 | 85 | 2021 |
| Increased platelet activation markers in rheumatoid arthritis: are they related with subclinical atherosclerosis? GE Pamuk, Ö Vural, B Turgut, M Demır, ÖN Pamuk, N Çakir Platelets 19 (2), 146-154, 2008 | 77 | 2008 |
| Leptin and resistin levels in serum of patients with hematologic malignancies: Correlation with clinical characteristic GE Pamuk, M Demir, F Harmandar, Y Yesil, B Turgut, Ö Vural Experimental oncology, 2006 | 76 | 2006 |
| Global fibrinolytic capacity in patients with subclinical hypothyroidism S Guldiken, M Demir, B Turgut, BU Altun, E Arikan, M Kara Endocrine journal 52 (3), 363-367, 2005 | 66 | 2005 |
| Serum osteoprotegerin levels in patients with acute atherothrombotic stroke and lacunar infarct B Guldiken, S Guldiken, B Turgut, N Turgut, M Demir, Y Celik, E Arikan, ... Thrombosis research 120 (4), 511-516, 2007 | 59 | 2007 |
| Overexpression of cyclooxygenase‐2 in multiple myeloma: association with reduced survival M Cetin, S Buyukberber, M Demir, I Sari, I Sari, K Deniz, B Eser, F Altuntas, ... American journal of hematology 80 (3), 169-173, 2005 | 59 | 2005 |
| 17p Deletion is associated with resistance of B-cell chronic lymphocytic leukemia cells to in vitro fludarabine-induced apoptosis B Turgut, O Vural, FS Pala, GE Pamuk, K Tabakcioğlu, M Demir, ... Leukemia & lymphoma 48 (2), 311-320, 2007 | 56 | 2007 |
| EORTC QLQ-C30 assessment in Turkish patients with hematological malignancies: association with anxiety and depression GE Pamuk, F Harmandar, N Ermantaş, O Harmandar, B Turgut, M Demir, ... Annals of Hematology 87, 305-310, 2008 | 53 | 2008 |
| The roles of oxidized low-density lipoprotein and interleukin-6 levels in acute atherothrombotic and lacunar ischemic stroke B Guldiken, S Guldiken, B Turgut, N Turgut, M Demir, Y Celik, E Arikan, ... Angiology 59 (2), 224-229, 2008 | 50 | 2008 |
| Hypercoagulopathy in stroke patients with nonvalvular atrial fibrillation: hematologic and cardiologic investigations N Turgut, O Akdemir, B Turgut, M Demir, G Ekuklu, Ö Vural, G Özbay, ... Clinical and applied thrombosis/hemostasis 12 (1), 15-20, 2006 | 50 | 2006 |
| Convalescent plasma therapy in patients with COVID‐19 TN Yiğenoğlu, T Hacıbekiroğlu, I Berber, MS Dal, A Baştürk, ... Journal of clinical apheresis 35 (4), 367-373, 2020 | 46 | 2020 |
| CD4+, CD25+, FOXP3+ T Regulatory Cell Levels in Obese, Asthmatic, Asthmatic Obese, and Healthy Children M Donma, E Karasu, B Ozdilek, B Turgut, B Topcu, B Nalbantoglu, ... Inflammation 38, 1473-1478, 2015 | 44 | 2015 |
| Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors S Başcı, N Ata, F Altuntaş, TN Yiğenoğlu, MS Dal, S Korkmaz, ... Journal of Oncology Pharmacy Practice 26 (7), 1676-1682, 2020 | 39 | 2020 |
| Oxidative stress and total antioxidant capacity in diabetic and nondiabetic acute ischemic stroke patients B Guldiken, M Demir, S Guldiken, N Turgut, B Turgut, A Tugrul Clinical and Applied Thrombosis/Hemostasis 15 (6), 695-700, 2009 | 39 | 2009 |
| Differences in platelet–leukocyte aggregates among subtypes of acute cerebral ischemia B Turgut, N Turgut, Y Çelik, E Tekgündüz, GE Pamuk, M Demir Journal of the neurological sciences 305 (1-2), 126-130, 2011 | 38 | 2011 |
| Increased circulating platelet–leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study GE Pamuk, B Turgut, ÖN Pamuk, Ö Vural, M Demir, N Çakr Blood coagulation & fibrinolysis 18 (4), 297-302, 2007 | 36 | 2007 |
